Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency

Arlt, Wiebke, Callies, Frank, van Vlijmen, Jan Christoph, Koehler, Ines, Reincke, Martin, Bidlingmaier, Martin, Huebler, Doris, Oettel, Michael, Ernst, Michael, Schulte, Heinrich Maria, Allolio, Bruno · 1999 · New England Journal of Medicine

Abstract

BACKGROUND: The physiologic role of dehydroepiandrosterone in humans is still unclear. Adrenal insufficiency leads to a deficiency of dehydroepiandrosterone; we therefore, investigated the effects of dehydroepiandrosterone replacement, in patients with adrenal insufficiency. METHODS: In a double-blind study, 24 women with adrenal insufficiency received in random order 50 mg of dehydroepiandrosterone orally each morning for four months and placebo daily for four months, with a one-month washout period. We measured serum steroid hormones, insulin-like growth factor I, lipids, and sex hormone-binding globulin, and we evaluated well-being and sexuality with the use of validated psychological questionnaires and visual-analogue scales, respectively. The women were assessed before treatment, after one and four months of treatment with dehydroepiandrosterone, after one and four months of placebo, and one month after the end of the second treatment period. RESULTS: Treatment with dehydroepiandrosterone raised the initially low serum concentrations of dehydroepiandrosterone, dehydroepiandrosterone sulfate, androstenedione, and testosterone into the normal range; serum concentrations of sex hormone-binding globulin, total cholesterol, and high-density lipoprotein cholesterol decreased significantly. Dehydroepiandrosterone significantly improved overall well-being as well as scores for depression and anxiety. For the global severity index, the mean (+/-SD) change from base line was -0.18+/-0.29 after four months of dehydroepiandrosterone therapy, as compared with 0.03+/-0.29 after four months of placebo (P=0.02). As compared with placebo, dehydroepiandrosterone significantly increased the frequency of sexual thoughts (P=0.006), sexual interest (P=0.002), and satisfaction with both mental and physical aspects of sexuality (P=0.009 and P=0.02, respectively). CONCLUSIONS: Dehydroepiandrosterone improves well-being and sexuality in women with adrenal insufficiency.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199909303411401

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Research works printed but not linked: 7

  1. Derogatis LR, 1973, Psychopharmacol Bull, 9, 13
  2. Franke HG, 1992, Diagnostica, 38, 160
  3. Steyer R, 1994, Diagnostica, 40, 320
  4. Brahler E, 1979, Psychother Med Psychol (Stuttg), 29, 14
  5. Herrmann C, 1994, Diagnostica, 40, 143
  6. 10.1210/jc.82.7.2363 · DOI · Paper page
  7. Casson PR, 1996, Int J Fertil Menopausal Stud, 41, 412

Cited by

See all 652

Metadata

Authors
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., & Allolio, B.
Affiliations
  • University of Würzburg (DE)
  • Universitätsklinikum Würzburg (DE)
  • München Klinik (DE)
Venue
New England Journal of Medicine
Published
1999-09-30
Volume
341
Issue
14
Pages
1013-1020
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2324268873
Cited by
644
References
30
Citations by year
2026: 6 · 2025: 5 · 2024: 10 · 2023: 8 · 2022: 13 · 2021: 11 · 2020: 13 · 2019: 6 · 2018: 11 · 2017: 14 · 2016: 15 · 2015: 22 · 2014: 19 · 2013: 17 · 2012: 20
FWCI
25.36
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
dehydroepiandrosterone, adrenal insufficiency, hormone replacement therapy, women, well-being, sexual function, sex hormone-binding globulin, androstenedione, testosterone, cholesterol, anxiety and depression, insulin-like growth factor I
MeSH terms
Adrenal Insufficiency, Adult, Affect, Androgens, Anxiety, Dehydroepiandrosterone, Depression, Double-Blind Method, Female, Humans, Lipids, Mental Health, Middle Aged, Surveys and Questionnaires, Sex Hormone-Binding Globulin, Cross-Over Studies, Sexuality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency. https://app.cochat.ai/papers/10.1056/nejm199909303411401
The paper
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., & Allolio, B. (1999). Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency. New England Journal of Medicine. https://doi.org/10.1056/nejm199909303411401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.